Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Perrigo Grows Into Adjacent Infant Formula Category With PBM Acquisition

This article was originally published in The Tan Sheet

Executive Summary

Perrigo takes the next step toward becoming a one-stop shop for private-label consumer health products with its $808 million acquisition of infant formula and baby food firm PBM Holdings Inc

Related Content

In Brief
Perrigo To Launch Private Label Mucinex, Prevacid, With An Eye On Lipitor
In Brief
Perrigo Sales Reach Record Highs Despite Manufacturing Restrictions
Perrigo Banks On Product Launches, OTC Switches For "Significant Growth"
Abbott's Similac Recall Triggers Overflow Demand For Answers
Perrigo gets go-ahead for new infant products
Perrigo Benefits From McNeil Recall, Prepares Infant Formula Launches
Mead Johnson Expands Presence In Emerging Markets With Middle East JV
Perrigo Pursues OTC Reimbursement Opportunity In Emerging "ORx" Space





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts